Steel Pipe Industry of Indonesia Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Steel Pipe Industry of Indonesia Tbk trades at Rp450 (market cap 3.31T, 1.33M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Steel Pipe Industry of Indonesia Tbk is far larger — about 31.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| ISSP | SCPI | |
|---|---|---|
Market Cap | 3.31T | 104.4B |
Volume | 1.33M | — |
Lot | 13.35K | — |
Turnover | 602.12M | — |
Average Price | 451.09 | — |
Value | 602.12M | — |
Indicative Equilibrium Price | 450 | — |
Indicative Equilibrium Volume | 2.63K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Steel Pipe Industry of Indonesia, PT (the Company) was established on January 30, 1971 based on notarial deed No. 109 of Djojo Muljadi, SH., Notary in Jakarta.
Read more on ISSP →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →